Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Legend Biotech (LEGN) Income from Continuing Operations (2019 - 2025)

Legend Biotech filings provide 7 years of Income from Continuing Operations readings, the most recent being 8500000.0 for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations fell 115.54% to 8500000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 70257000.0, a 49.56% increase, with the full-year FY2025 number at 268400000.0, down 92.82% from a year prior.
  • Income from Continuing Operations hit 8500000.0 in Q4 2025 for Legend Biotech, up from 38457000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 112101000.0 in Q1 2023 to a low of 198548000.0 in Q2 2023.
  • Median Income from Continuing Operations over the past 5 years was 61283000.0 (2023), compared with a mean of 55258274.55.
  • Biggest five-year swings in Income from Continuing Operations: crashed 32288.91% in 2022 and later soared 36859.27% in 2024.
  • Legend Biotech's Income from Continuing Operations stood at 84721000.0 in 2021, then tumbled by 60.02% to 135570000.0 in 2022, then surged by 99.89% to 148806.0 in 2023, then soared by 36859.27% to 54700000.0 in 2024, then plummeted by 115.54% to 8500000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 8500000.0 (Q4 2025), 38457000.0 (Q3 2025), and 124216000.0 (Q2 2025) per Business Quant data.